Search

everythinglearnresearchcommunity

for

Search:↓

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Lichen planopilaris can be accurately diagnosed and effectively treated.

Isotretinoin effectively treated a rare scalp condition, but careful drug monitoring and a dairy-free diet were important.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Minoxidil and Finasteride are effective for male baldness; more research is needed for hair aging treatments.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Menopause can cause skin issues, and seeing a dermatologist helps.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Menopause can lead to skin and hair problems due to hormonal changes, but hormone replacement therapy might help slow these effects.

The document concludes that identifying the cause of eyebrow and eyelash loss is key to treating it and improving quality of life.

Losing eyelashes or eyebrows can be a sign of many different health problems and needs a careful approach to treat effectively.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

The most common skin problems in perimenopausal women in South India are infections, eczemas, and acne, possibly worsened by external factors and lifestyle practices.

Frontal fibrosing alopecia is a type of hair loss that usually happens after menopause.

A woman's skin darkened after using dutasteride and pimecrolimus for hair loss, but improved when she stopped the medications and protected her skin from light.

Female pattern hair loss diagnosis is challenging and should use dermoscopy and histopathology instead of pattern recognition, as hormones may not always be the cause.

Frontal fibrosing alopecia may be caused by an autoimmune reaction and hormonal imbalance.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

The study suggests hormonal factors may play a role in Frontal Fibrosing Alopecia and that treatments like oral antiandrogens and steroids could be beneficial.

Early diagnosis and treatment of frontal fibrosing alopecia are crucial to prevent permanent hair loss.

5-Alpha-Reductase inhibitors might help slow down hair loss in Frontal Fibrosing Alopecia but are not a primary treatment and need more research.

Frontal fibrosing alopecia is increasing, especially in postmenopausal women, and treatment with finasteride can improve it.

Cosmetic products or emotional factors might contribute to Frontal Fibrosing Alopecia, and trichoscopy is useful for diagnosis.

The exact cause of frontal fibrosing alopecia is unknown, but it's not likely due to sunscreen.

A rare case of a woman having both lichen planus pigmentosus and classic lichen planopilaris at the same time.

Isolated long hairs at the original hairline can help diagnose Frontal Fibrosing Alopecia.

Frontal Fibrosing Alopecia is a type of hair loss that mainly affects postmenopausal women, has unclear causes, and lacks evidence-based treatments.

Eyebrow loss in frontal fibrosing alopecia is common and may be linked to other health issues.